IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · IEX Real-Time Price · USD
9.48
-0.15 (-1.56%)
At close: May 1, 2024, 4:00 PM
9.69
+0.21 (2.22%)
After-hours: May 1, 2024, 4:14 PM EDT
IGM Biosciences Revenue
In the year 2023, IGM Biosciences had annual revenue of $2.13M with 99.25% growth. Revenue in the quarter ending December 31, 2023 was $651.00K with 75.00% year-over-year growth.
Revenue (ttm)
$2.13M
Revenue Growth
+99.25%
P/S Ratio
262.36
Revenue / Employee
$9,509
Employees
224
Market Cap
558.82M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.13M | 1.06M | 99.25% |
Dec 31, 2022 | 1.07M | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIGMS News
- 14 days ago - IGM Biosciences Announces Refocusing of Sanofi Collaboration - GlobeNewsWire
- 21 days ago - IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum - GlobeNewsWire
- 7 weeks ago - IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewsWire
- 4 months ago - IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Medivir to present at the Carlsquare Equity Research Investor Day - PRNewsWire
- 5 months ago - IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension - GlobeNewsWire
- 5 months ago - Bulletin from Extraordinary General Meeting in Medivir AB (publ) - PRNewsWire